• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: CHRISTOPH MIETHKE GMBH & CO KG SPRUNG RESERVOIR-SET M.DISTALEM KATHETER; HYDROCEPHALUS MANAGEMENT

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

CHRISTOPH MIETHKE GMBH & CO KG SPRUNG RESERVOIR-SET M.DISTALEM KATHETER; HYDROCEPHALUS MANAGEMENT Back to Search Results
Model Number FV046T
Device Problem Infusion or Flow Problem (2964)
Patient Problems Head Injury (1879); Hemorrhage/Bleeding (1888); Hydrocephalus (3272)
Event Date 04/09/2021
Event Type  Injury  
Manufacturer Narrative
Additional information/ investigation result will be submitted in a supplemental report.
 
Event Description
It was reported that there was an issue with fv046t + fx417t shunt system.According to the complainant, the valve was believed to be operating with blockage.The patient underwent a revision procedure.The complainant device was returned to the manufacturer for evaluation.No patient complications were reported as a result of the revision procedure.Patient information: age: (b)(6) years.Explantation: (b)(6) 2021.The same event: medwatch#3004721439-2021-00134.
 
Manufacturer Narrative
The same event: medwatch#3004721439-2021-00134.Investigation: visual inspection: no abnormalities were detected during the visual inspection.Permeability test: the test showed that the sprung reservoir is permeable, filled with liquid and pumpable.Results: based on our investigation results, we cannot identify a malfunction of the reservoir.However, we assume that the significant deposits found within the combined progav 2.0 valve (rm 3884 - 400511420) may have temporarily caused the functional impairment.Deposits caused by natural substances in the cerebrospinal fluid, such as protein, blood or tissue particles, are among the known and unavoidable risks and side effects of hydrocephalus therapy.Small amounts of non-visible deposits/proteins might compromise the integrity of the system.We can exclude a defect at the time of release.All products met all specifications of the final inspection when released from christoph miethke gmbh & co.Kg.From our point of view, no further regulatory actions are required.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
SPRUNG RESERVOIR-SET M.DISTALEM KATHETER
Type of Device
HYDROCEPHALUS MANAGEMENT
Manufacturer (Section D)
CHRISTOPH MIETHKE GMBH & CO KG
ulanenweg 2
potsdam, 14469
GM  14469
MDR Report Key11849734
MDR Text Key251451742
Report Number3004721439-2021-00133
Device Sequence Number1
Product Code JXG
UDI-Device Identifier04041906136598
UDI-Public4041906136598
Combination Product (y/n)N
PMA/PMN Number
K110206
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative,user f
Type of Report Initial,Followup
Report Date 06/22/2021
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Model NumberFV046T
Device Catalogue NumberFV046T
Was Device Available for Evaluation? Device Returned to Manufacturer
Date Returned to Manufacturer05/17/2021
Initial Date Manufacturer Received 04/21/2021
Initial Date FDA Received05/19/2021
Supplement Dates Manufacturer Received06/17/2021
Supplement Dates FDA Received06/22/2021
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
Patient Outcome(s) Required Intervention;
Patient Age59 YR
-
-